EIF3A and diffuse large B-cell lymphoma: DLBCL patients in GSE31312 dataset were divided into two groups based on eIF3a expression (Figure S2A), patients with high eIF3a expression had worse prognosis compared to these with low level (Fig. 1B, P = 0.0063).